
The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications
Keywords: انعقاد داخل عضلانی; Brain injury; Cost-effectiveness; Factor VII; Hematoma; Intravascular coagulation; Thrombosis